Vitrolife
103,60 SEK
-0,67 %
Mindre end 1K følgere
VITR
NASDAQ Stockholm
Biotechnology & Pharmaceuticals
Health Care
Oversigt
Finansielt overblik og estimater
Ejerskab
Dividend
Investorkonsensus
Værdiansættelse
Resultatopgørelse
Kvartalsdata
Kvartalsdata
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Vitrolife
| Q4/24 | 2024 | Q1/25 | Q2/25 | Q3/25 | Q4/25 | 2025 | Q1/26 | |
|---|---|---|---|---|---|---|---|---|
| Omsætning | 960,0 | 3.609,0 | 842,0 | 871,0 | 835,0 | 892,0 | 3.440,0 | 807,0 |
| EBITDA | 337,0 | 962,0 | 257,0 | 243,0 | 253,0 | 196,0 | 949,0 | 251,0 |
| EBIT | 224,0 | 783,0 | 151,0 | 137,0 | 144,0 | -5.267,0 | -4.835,0 | 149,0 |
| EBIT-% | 23,3 % | 21,7 % | 17,9 % | 15,7 % | 17,2 % | -590,5 % | -140,6 % | 18,5 % |
| Overskud før skat | 183,0 | 674,0 | 141,0 | 132,0 | 131,0 | -5.290,0 | -4.886,0 | 130,0 |
| Netto indkomst | 140,0 | 514,0 | 100,0 | 100,0 | 102,0 | -5.315,0 | -5.013,0 | 101,0 |